The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience

Journal of Viral Hepatitis
R BielenG Robaeys

Abstract

Recently, concerns were raised of high rates of HCC recurrence in patients treated with direct-acting antivirals (DAA) for hepatitis C infection. We investigated the HCC occurrence and recurrence rates within 6 months after treatment with DAA with or without pegylated interferon (PEG-IFN) in real life. This is a retrospective, multicenter cohort trial, executed in 15 hospitals distributed across Belgium. Populations were matched based on fibrosis score (Metavir F3-F4). Patients with a Child-Pugh score ≥ B were excluded. In total, 567 patients were included, of whom 77 were treated with PEG-IFN+DAA between 2008 and 2013 and 490 with DAA without PEG-IFN between 2013 and 2015. Patients treated with PEG-IFN+DAA (53±9y) were younger than patients treated with DAA without PEG-IFN (59±12y) (P=.001). 47% of patients treated with PEG-IFN+DAA were in the F4 stage vs 67% of patients treated with DAA without PEG-IFN (P=.001). Screening was inadequate in 20% of both patient groups (P=.664). The early occurrence rate of HCC was 1.7% and 1.1% in patients treated with DAA with and without PEG-IFN, respectively (P=.540). The early recurrence rate was 0% in patients treated with PEG-IFN+DAA and 15.0% in patients treated with DAA without PEG-IFN ...Continue Reading

References

Nov 26, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C NiederauD Häussinger
Jun 27, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Eiko HasegawaHiromitsu Kumada
Aug 8, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Savino BrunoMario U Mondelli
Dec 10, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yun Ku ChoJoon Koo Han
Jun 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Timothy R MorganUNKNOWN HALT-C Trial Group
Sep 20, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yasuji AraseTetsuro Kobayashi
Dec 27, 2012·JAMA : the Journal of the American Medical Association·Adriaan J van der MeerHarry L A Janssen
Jan 17, 2014·The New England Journal of Medicine·Mark S SulkowskiUNKNOWN AI444040 Study Group
Apr 12, 2014·The New England Journal of Medicine·Kris V KowdleyUNKNOWN ION-3 Investigators
Apr 12, 2014·The New England Journal of Medicine·Jordan J FeldBarry Bernstein
Nov 12, 2014·JAMA : the Journal of the American Medical Association·Adriaan J van der MeerHarry L A Janssen
Apr 8, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K Rajender ReddyNezam Afdhal
Jun 3, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Varun SaxenaNorah A Terrault
Nov 17, 2015·The New England Journal of Medicine·Michael P CurryUNKNOWN ASTRAL-4 Investigators
Nov 17, 2015·The New England Journal of Medicine·Jordan J FeldUNKNOWN ASTRAL-1 Investigators
Nov 18, 2015·The New England Journal of Medicine·Graham R FosterUNKNOWN ASTRAL-3 Investigators
Mar 31, 2016·Journal of Viral Hepatitis·Mei LuUNKNOWN CHeCS Investigators
Jun 4, 2016·Journal of Hepatology·Calogero CammàAntonio Craxì
Jun 12, 2016·Journal of Hepatology·UNKNOWN ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts). Electr

❮ Previous
Next ❯

Citations

Apr 3, 2018·Journal of Clinical and Translational Hepatology·Page AxleyAshwani K Singal
Aug 8, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·L P ZanagaR S B Stucchi
Jul 10, 2018·The Journal of Antimicrobial Chemotherapy·Nicolás MerchanteUNKNOWN Members of the HEPAVIR-Cirrhosis Study Group
Oct 12, 2018·Viruses·Pierre PradatEric Trépo
Jun 7, 2019·Clinical Liver Disease·Feng Su, George N Ioannou
Jul 3, 2018·World Journal of Gastroenterology : WJG·Maria GuarinoUNKNOWN Special Interest Group on “Hepatocellular carcinoma and new anti-HCV therapies” of the Italian Association for the Study of
Feb 3, 2021·Gastroenterology·Don C Rockey, Scott L Friedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.